Asthma
COPD
Pulmonary
Pulmonary: Page 6
Iron’s complex association with chronic lung infections
An iron-rich environment can impact bacterial growth and pulmonary health.
February 19, 2026
Impact of vitamin D on respiratory function
Deficient levels increase risk of severe infection and hospitalization.
February 13, 2026
Raising awareness of drug-induced pneumonitis
Research emphasizes the importance of recognizing signs of the complication before it becomes life-threatening.
February 11, 2026
Sponsored
Pulmonary fibrosis insight
Ascend Media
The 2026 report provides global pipeline therapies in various clinical trial stages.
August 10, 2026
Lab-grown lung tumors: the new test subject
Scientists believe the innovative model can improve CAR-T therapy and advance precision medicine.
February 10, 2026
Pediatric trial of Uptravi shows early promising results
The phase 2 study assessed a dosing schedule for children with pulmonary arterial hypertension.
January 30, 2026
Combination therapy eliminates cancer-resistant lung cells
The novel approach includes ERBB and Aurora kinase inhibitors to treat KRAS-mutated lung adenocarcinomas.
January 27, 2026
Sponsored
CDC vaccine schedules
Ascend Media
View the most recent vaccine recommendations for infants, young children and teens.
July 21, 2026
Scientists make progress in developing pulmonary mRNA vaccine
The innovative, inhaled technology would enable targeted delivery to immune cells in lungs to fight disease.
January 23, 2026
Fixing blood vessel growth in BPD before it’s too late
UCLA study identifies the regulatory pathways that drive molecular switch impairing lung growth and function.
January 20, 2026
Developmental drug releases antibiotic to treat severe pneumonia
The engineered therapy carries medicine to lung immune cells to kill bacteria.
January 13, 2026
Sponsored
Pulmonary fibrosis insight
Ascend Media
The 2026 report provides global pipeline therapies in various clinical trial stages.
August 10, 2026
Researchers identify neutrophils that trigger PANoptosis, acute lung injury
The discovery sheds new light on complex immune responses in sepsis and reveals a promising treatment for this life-threatening disease.
January 13, 2026
FDA approves nerandomilast for adults with PPF
Progressive pulmonary fibrosis becomes the second authorized indication for the drug therapy in the United States.
January 9, 2026
CS1 clears hurdle to begin dose-finding trial for PAH
The developmental drug has previously demonstrated safety, tolerability and early disease-modifying outcomes.
January 8, 2026
Previous Page
Page 6 of 29
Next Page
Most Popular
Is there a ‘window of opportunity’ for biologic treatment in severe asthma?
FDA approves study of inhaled stem cell therapy for COPD
Semaglutide significantly lowers asthma, COPD attacks
Common cold: There may be a vaccine for that
Novel inhaled treatment for COPD shows promise in clinical trial
MRI reduces cognitive failure, adverse events in SCLC